|
|
Other links at Articles > Gastroenterology |
| 3. |
Etravirine Does Not Appear to Be Hepatotoxic
|
|
|
Longer term follow-up of the recently approved non-nucleoside reverse transcriptase inhibitor (NNRTI) etravirine (Intelence; Tibotec Therapeutics) for the treatment of HIV infection shows that etravirine does not appear to cause elevations in serum alanine transaminase levels (ALT) or other signs of hepatotoxicity, researchers announced here at the annual meeting of the American Association for the Study of Liver Diseases. Reuters Health Information
|
|
|